Recommendations made by the PBAC – November 2024

20 December 2024 - Recommendations made by the PBAC in November 2024 relating to the listing of medicines on the PBS ...

Read more →

Outcomes of the September 2024 PBAC intracycle meeting

18 October 2024 - The outcomes from the September 2024 PBAC intracycle meeting are now available. ...

Read more →

Recommendations made by the PBAC – July 2024

23 August 2024 - Recommendations made by the PBAC in July 2024 relating to the listing of medicines on the ...

Read more →

Outcomes from the May 2024 PBAC intracycle meeting

21 June 2024 - Recommendations made by the PBAC in May 2024 relating to the listing of medicines on the PBS ...

Read more →

Life prolonging breast cancer drug recommended for PBS subsidy, but it is not time to celebrate

26 April 2024 - Breast Cancer Network Australia (BCNA) today welcomed a decision by the PBAC to recommend the life ...

Read more →

Recommendations made by the PBAC (March 2024)

26 April 2024 - Recommendations made by the PBAC in March 2024 relating to the listing of medicines on the PBS ...

Read more →

Outcome statement - February 2024 DUSC meeting

22 March 2024 - The Outcome Statement from the February 2024 DUSC meeting is now available. ...

Read more →

More rare conditions considered for newborn bloodspot screening and new treatment option for spinal muscular atrophy

29 February 2024 - On Rare Disease Day, the Albanese Government has announced two more rare genetic conditions have been ...

Read more →

Outcomes from the December 2023 PBAC intracycle meeting

25 January 2024 - The outcomes from the December 2023 PBAC intracycle meeting are now available. ...

Read more →

Recommendations made by the PBAC (November 2023)

18 December 2023 - Recommendations made by the PBAC in November 2023 relating to the listing of medicines on the ...

Read more →

Outcomes of the September 2023 PBAC intracycle meeting

13 October 2023 - The outcomes from the September 2023 PBAC intracycle meeting are now available. ...

Read more →

Australia knocks back application for diabetes drug that could overshadow Ozempic

29 August 2023 - Australia has knocked back an application to subsidise the diabetes drug Mounjaro but the manufacturer still wants ...

Read more →

Recommendations made by the PBAC (July 2023)

18 August 2023 - Recommendations made by the PBAC in July 2023 relating to the listing of medicines on the ...

Read more →

Estimating overall survival in people receiving PBS listed cancer medicines in Australian clinical practice

18 August 2023 - In September 2021, the Department of Health and Aged Care contracted the Medicines Intelligence Centre for ...

Read more →

Outcome statement - June 2023 DUSC meeting

18 July 2023 - The outcome statement from the June 2023 DUSC meeting is now available. ...

Read more →